Pipeline
2021 status
PROGRAM
DISEASE
DISCOVERY
DEVELOPMENT
PHASE 1B
PHASE 2
PHASE 3
Memory NK
AML, MDS
WU-NK-101
WU-NK
WU-NK-101
Solid Tumors
WU-NK-201
WU-CART-007
WU-CART
T-ALL, T-NHL
WU-CART-002
WU-ALLO-1
WU-ALLO
AML, MDS
WU-ALLO-2
WU-ALLO-3
AML = Acute Myeloid Leukemia
MDS = Myelodysplastic syndrome
T-ALL = T-cell Acute Lymphoblastic Leukemia
T-NHL = T-cell Non-Hodgkin’s Lymphoma
